Pooled Analysis on the Effectiveness and Safety of Lipegfilgrastim in Patients With Urological Malignancies in the Real-World Setting

Pooled Analysis on the Effectiveness and Safety of Lipegfilgrastim in Patients With Urological Malignancies in the Real-World Setting

Lipegfilgrastim is a long-acting glycopegylated granulocyte-colony stimulating factor (G-CSF) approved for the management of chemotherapy-induced neutropenia. In general, there is little information on the use of any G-CSFs specifically in patients with urological malignancies receiving chemotherapy...

Full description

Bibliographic Details
Main Authors: Axel S. Merseburger, Götz Geiges, Jörg Klier, Martin Wiesholzer, Petra Pichler
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
lipegfilgrastim
prostate
testicular
bladder
cancer
neutropenia
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.655355/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.655355/full

Similar Items